HK Stock MarketDetailed Quotes

02325 YUNKANG GROUP

Watchlist
  • 7.540
  • -0.040-0.53%
Market Closed Dec 20 16:08 CST
4.68BMarket Cap-15.42P/E (TTM)

About YUNKANG GROUP Company

Yunkang Group is a medical operation service provider in China. As early as 2008, Yunkang began providing standardized medical diagnostic services to medical institutions at all levels. Through the use of its own professional diagnostic capabilities and a nationwide medical consortium service network, Yunkang has gradually developed into a leading platform for medical operation services. Its testing programs have continued to increase. In 2021, it has carried out more than 2,000 testing projects and more than 50 million diagnostic tests. As far as revenue in 2020 is concerned, as one of the top five companies in the Chinese medical operation service market, we have three major business lines, covering diagnostic testing services for medical consortia, diagnostic outsourcing services, and diagnostic testing services for non-medical institution customers. As of April 25, 2022, from the establishment of six major operating modules and seven major technology platforms to six independent clinical laboratories covering key provinces and cities across the country, Yunkang has the largest number of first-class independent laboratories with both ISO15189 and CAP accreditation in the country, and more than 1,450 medical technicians. We have provided comprehensive and high-quality clinical diagnosis services to partner hospitals for a long time with accurate clinical diagnosis capabilities. At the same time, Yunkang is also a leading provider of medical consortium diagnostic services in China, providing a full range of medical and health services covering medical consortium diagnosis and diagnosis outsourcing. Yunkang provides diagnostic testing services to partner hospitals within the Chinese Medical Federation, and assists them in improving their clinical diagnosis capabilities through on-site diagnosis centers. Up to now, Yunkang has successfully provided professional services to more than 700 medical institutions from more than 300 medical consortia across the country. As of December 31, 2021, our partner hospitals are distributed in 31 provinces and cities in China, most of which are located in Guangdong Province, where our headquarters are located. Over the past ten years, Yunkang has achieved sustainable growth through professional medical diagnosis services, strong standardization capabilities, innovative diagnostic testing service business models for the medical community, a large loyal customer base, and a visionary and experienced management team. Technology is healthy, and health is served! Yunkang will continue to work to create a better and healthier life for the general public.

Company Profile

Symbol02325
Company NameYUNKANG GROUP
ISINKYG9889T1067
Listing DateMay 18, 2022
Issue Price7.89
Shares Offered138.19M share(s)
FoundedJul 20, 2018
Registered AddressCayman Islands
Chairmanyong zhang
Secretaryyingjialinzhiqing lin
Audit InstitutionCCA Zhonghuan (Hong Kong) Certified Public Accountants Limited
Company CategoryOverseas registration of Mainland Individuals control
Registered OfficePO Box 31119 Grand Pavilion Hibiscus Way 802 West Bay Road Grand Cayman KY1-1205 Cayman Islands
Head Office and Principal Place of Business4th Floor, Jardine House, 1 Connaught Place, Central, Hong Kong
Fiscal Year Ends12-31
Employees1459
MarketHong Kong motherboard
Phone(020)32106666;(800)8303620;(400)8303621
Fax32106638
Emailir@yunkanghealth.com
Business Yunkang Group Co., Ltd. is an investment holding company mainly engaged in providing diagnostic testing services. The company's service portfolio mainly includes three services. Diagnostic outsourcing services are engaged in providing outsourced diagnostic services to hospitals, other medical institutions and public health institutions. The diagnostic and testing services provided to the medical consortium are aimed at assisting hospitals in establishing on-site diagnostic centers in the fields of infectious diseases, reproductive health, genetic diseases, and pathology, and providing hospitals with comprehensive solutions including testing technology, professional and technical personnel. Diagnostic testing services for non-medical institutions provide personalized diagnostic tests, medical report consultation, and hospital referral services. The company operates in the domestic market.

Company Executives

  • Name
  • Position
  • Salary
  • yong zhang
  • Presidencies, CEO, Executive Director, Chairman of the Nomination Committee, Remuneration Committee Members, Authorized Representative
  • --
  • luo huang
  • Non-executive Directors
  • --
  • pinghui wang
  • Non-executive Directors
  • 76.00K
  • ruihua wang
  • Non-executive Directors, Audit Committee Members
  • 227.00K
  • shiyou yu
  • Independent Non-Executive Director, Remuneration Committee Chairman, Audit Committee Members, Nomination Committee Members
  • --
  • fenghui lan
  • Independent Non-Executive Director
  • 76.00K
  • shaohua xie
  • Independent Non-Executive Director, Chairman of the Audit Committee, Remuneration Committee Members, Nomination Committee Members
  • --
  • xubo wang
  • Executive Vice President
  • --
  • yingjia lin
  • Chief Financial Officer, Joint Company Secretary
  • --
  • shanghua hu
  • VP
  • --
  • tieding wang
  • VP
  • --
  • zhiqing lin
  • Joint Company Secretary, Authorized Representative
  • --
Heat List
HK
Overall
Symbol
Price
% Chg

No Data